Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FP4E2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,056
Award facts
- Contract value 100% obligated
- $28,055.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $28,056 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injections (2 mL units). This competitive, non-set-aside contract was executed on July 8, 2025, with an ultimate completion date of July 9, 2025, and is characterized by firm fixed pricing. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary distribution hub for federal medical procurement operations.
This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which extends through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The DLA Troop Support Medical Supply Chain utilizes such contracts to maintain consistent access to critical medications, including specialty biologics like Dupixent, which is indicated for conditions including atopic dermatitis and asthma. AmerisourceBergen's role as a pharmaceutical prime vendor reflects its status as a major healthcare solutions provider serving the Defense Health Agency, U.S. Coast Guard, and other federal medical systems.
Quick answers
Who was awarded contract SPE2DB25FP4E2?
SPE2DB25FP4E2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 8, 2025.
How much is contract SPE2DB25FP4E2 worth?
The government has obligated $28,056 on SPE2DB25FP4E2.
Is contract SPE2DB25FP4E2 an order under another contract?
Yes. SPE2DB25FP4E2 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP4E2 competed?
The extent of competition for SPE2DB25FP4E2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award